Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (581-590 of 663) with videos related to

Pageof 67
Sort By:
European Journal of Heart Failure|June 17, 2000
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of YorkJ G Cleland, K Swedberg, A Cohen-Solal, et al.
Journal of the American College of Cardiology|December 21, 2013
The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)Michael Mielewczik, Graham D Cole, Alexandra N Nowbar, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
European Journal of Heart Failure|April 17, 2023
A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trialMasatake Kobayashi, Olivier Huttin, João Pedro Ferreira, et al.
International Journal of Cardiology|September 22, 2023
Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17DLukas Baumhove, Nils Bomer, Jasper Tromp, et al.
European Journal of Heart Failure|March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failureBiniyam G Demissei, Douwe Postmus, John G Cleland, et al.
European Journal of Heart Failure|June 24, 2021
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHFMatteo Pagnesi, Marianna Adamo, Iziah E Sama, et al.
Cardiovascular Research|July 15, 2021
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHFGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
International Journal of Cardiology|December 23, 2023
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHFMarianna Adamo, Matteo Pagnesi, Mattia Di Pasquale, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
Pageof 67

Showing results (581-590 of 663) with videos related to

Sort By:
Pageof 67
European Journal of Heart Failure|June 17, 2000
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of YorkJ G Cleland, K Swedberg, A Cohen-Solal, et al.
Journal of the American College of Cardiology|December 21, 2013
The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)Michael Mielewczik, Graham D Cole, Alexandra N Nowbar, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
European Journal of Heart Failure|April 17, 2023
A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trialMasatake Kobayashi, Olivier Huttin, João Pedro Ferreira, et al.
International Journal of Cardiology|September 22, 2023
Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17DLukas Baumhove, Nils Bomer, Jasper Tromp, et al.
European Journal of Heart Failure|March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failureBiniyam G Demissei, Douwe Postmus, John G Cleland, et al.
European Journal of Heart Failure|June 24, 2021
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHFMatteo Pagnesi, Marianna Adamo, Iziah E Sama, et al.
Cardiovascular Research|July 15, 2021
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHFGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
International Journal of Cardiology|December 23, 2023
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHFMarianna Adamo, Matteo Pagnesi, Mattia Di Pasquale, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
Pageof 67